Aptevo Therapeutics Inc. — Director's Dealing 2019

Jun 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2019-06-01

Reporting Person: Harsanyi Zsolt (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-01	Option (right to buy)	$0.7250	A	25000	Acquired	2029-06-01	Aptevo Therapeutics Inc. common stock (25000)	Direct

Footnotes

F1: The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020.